Bioequivalence of Pramipexole Extended Release (PPX ER) 1.5mg x 1 Tablet Once Daily (q.d.) vs. PPX ER 0.375mg x 4 Tablets Under Fasted and Fed Conditions in Japanese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2010

Conditions
Healthy
Interventions
DRUG

PPX ER

PPX ER 0.375mg - 1.5mg for 32 days totally

DRUG

PPX ER

PPX ER 0.375mg - 1.5mg for 32 days totally

Trial Locations (1)

Unknown

248.677.001 Boehringer Ingelheim Investigational Site, Sumida-ku, Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY